ALEAF logo

Aleafia Health Inc. (ALEAF) Aktienanalyse

Nur zu Informationszwecken. Keine Finanzberatung. Analysis by Sedat Aydin, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.

Aleafia Health Inc. (ALEAF) ist im Healthcare-Sektor taetig, zuletzt notiert bei $ mit einer Marktkapitalisierung von 0. Bewertet mit 38/100 (vorsichtig) bei Wachstumspotenzial, finanzieller Gesundheit und Momentum.

Zuletzt analysiert: 17. März 2026
38/100 KI-Bewertung

Aleafia Health Inc. (ALEAF) Gesundheitswesen & Pipeline-Uebersicht

CEOPatricia Symmes
Mitarbeiter158
HauptsitzConcord, CA
IPO-Jahr2018

Aleafia Health Inc. is a Canadian cannabis company producing cannabis oils, capsules, edibles, and dried flower, operating a virtual network of medical cannabis clinics. With a focus on health and wellness, Aleafia distributes its products under various brands in a competitive market, facing challenges in profitability and market share.

Datenherkunft | Finanzdaten Quantitative Analyse NASDAQ Analyse: 17. März 2026

Investmentthese

Aleafia Health Inc. presents a speculative investment opportunity in the cannabis sector. The company's diverse product portfolio and clinic network offer potential revenue streams, but its negative profit margin of -98.8% raises concerns about financial sustainability. The high beta of 2.08 indicates significant volatility relative to the market. Growth catalysts include expansion of its product lines and increased market penetration in Canada and internationally. However, the company faces risks related to regulatory changes, competition, and achieving profitability. Investors should carefully consider these factors before investing.

Basierend auf FMP-Finanzdaten und quantitativer Analyse

Wichtige Highlights

  • Aleafia Health Inc. operates in the cannabis health and wellness sector, offering a diverse range of products including oils, capsules, edibles, and dried flower.
  • The company owns and operates a virtual network of medical cannabis clinics, providing consultations and treatment plans to patients.
  • Aleafia Health's product portfolio is marketed under various brands, including Divvy, Sunday Market, Bogart's Kitchen, and Emblem.
  • The company's gross margin is 14.0%, indicating a relatively low level of profitability.
  • Aleafia Health's market capitalization is $0.00B, reflecting its small size and potential for growth or volatility.

Wettbewerber & Vergleichsunternehmen

Staerken

  • Diverse product portfolio including oils, edibles, and dried flower.
  • Virtual network of medical cannabis clinics.
  • Established brands such as Divvy and Emblem.
  • International presence.

Schwaechen

  • Negative profit margin of -98.8%.
  • High beta of 2.08 indicating high volatility.
  • Limited market capitalization of $0.00B.
  • Reliance on evolving cannabis regulations.

Katalysatoren

  • Upcoming: Potential regulatory changes in cannabis laws could expand market access.
  • Ongoing: Expansion of the company's product lines to include new cannabis-based products.
  • Ongoing: Increased market penetration in Canada and internationally through strategic partnerships.
  • Ongoing: Development of proprietary cannabis strains with unique characteristics.

Risiken

  • Ongoing: Increasing competition from other cannabis producers in a saturated market.
  • Potential: Regulatory changes impacting cannabis production and sales could negatively affect revenue.
  • Potential: Fluctuations in cannabis prices could impact profitability.
  • Potential: Product recalls or safety concerns could damage the company's reputation.
  • Ongoing: The company's negative profit margin of -98.8% raises concerns about financial sustainability.

Wachstumschancen

  • Expansion of Product Lines: Aleafia Health can expand its product lines to include new and innovative cannabis-based products. The market for cannabis edibles, beverages, and topicals is growing rapidly, offering opportunities for the company to capture additional market share. The timeline for product development and launch is approximately 6-12 months, and the market size for these products is estimated to be in the hundreds of millions of dollars.
  • Increased Market Penetration: Aleafia Health can increase its market penetration in Canada and internationally by expanding its distribution network and marketing efforts. The company can target specific customer segments, such as medical cannabis patients and recreational users, with tailored products and services. The timeline for market expansion is approximately 12-24 months, and the market size is estimated to be in the billions of dollars.
  • Strategic Partnerships: Aleafia Health can form strategic partnerships with other companies in the cannabis industry, such as retailers, distributors, and technology providers. These partnerships can help the company expand its reach, improve its efficiency, and access new technologies. The timeline for forming strategic partnerships is approximately 6-12 months, and the potential benefits are significant.
  • Development of Proprietary Strains: Aleafia Health can develop proprietary strains of cannabis with unique characteristics and benefits. These strains can be used to create differentiated products that appeal to specific customer segments. The timeline for developing proprietary strains is approximately 12-24 months, and the potential for increased profitability is significant.
  • Expansion of Clinic Network: Aleafia Health can expand its virtual network of medical cannabis clinics to reach more patients and provide access to cannabis-based treatments. The company can also offer new services, such as telemedicine consultations and personalized treatment plans. The timeline for expanding the clinic network is approximately 6-12 months, and the potential for increased revenue is significant.

Chancen

  • Expansion of product lines to include new cannabis-based products.
  • Increased market penetration in Canada and internationally.
  • Strategic partnerships with other companies in the cannabis industry.
  • Development of proprietary cannabis strains.

Risiken

  • Increasing competition from other cannabis producers.
  • Regulatory changes impacting cannabis production and sales.
  • Fluctuations in cannabis prices.
  • Potential for product recalls or safety concerns.

Wettbewerbsvorteile

  • Brand recognition through established brands like Divvy and Emblem.
  • Virtual network of medical cannabis clinics provides direct access to patients.
  • Diverse product portfolio caters to various consumer preferences.
  • Proprietary strains and formulations offer unique product offerings.

Ueber ALEAF

Aleafia Health Inc. is a cannabis health and wellness company operating in Canada and internationally. The company was founded with the vision of providing cannabis-based solutions for medical and recreational use. Aleafia's product portfolio includes cannabis oils, capsules, edibles, cannabis-infused sublingual strips, vape cartridges, bath bombs, soft gels, hang dried, hand trimmed, long cured, and small batch dried flower, and concentrates. These products are marketed under brands like Divvy, Sunday Market, Bogart's Kitchen, Noon & Night, Nith & Grand, Kin Slips, and Emblem. Beyond product manufacturing, Aleafia Health also operates a virtual network of medical cannabis clinics staffed by physicians and nurse practitioners, offering consultations and treatment plans to patients. Additionally, the company runs education centers aimed at increasing awareness and understanding of cannabis and its potential benefits. Aleafia Health is headquartered in Concord, Canada, and serves both domestic and international markets. The company faces competition from other cannabis producers and healthcare providers in the rapidly evolving cannabis industry.

Was das Unternehmen tut

  • Cultivates and processes cannabis.
  • Manufactures cannabis oils, capsules, and edibles.
  • Produces cannabis-infused sublingual strips and vape cartridges.
  • Offers bath bombs and soft gels.
  • Sells hang dried, hand trimmed, long cured, and small batch dried flower.
  • Produces cannabis concentrates.
  • Operates a virtual network of medical cannabis clinics.
  • Runs education centers.

Geschaeftsmodell

  • Cultivation and processing of cannabis.
  • Manufacturing and sale of cannabis products.
  • Operation of medical cannabis clinics.
  • Provision of cannabis education services.

Branchenkontext

Aleafia Health operates within the rapidly evolving cannabis industry, which is experiencing significant growth and regulatory changes. The market is becoming increasingly competitive, with numerous companies vying for market share. Aleafia Health competes with other cannabis producers and healthcare providers in Canada and internationally. The industry is subject to evolving regulations, which can impact the company's operations and profitability. Trends include increasing demand for cannabis-based health and wellness products, as well as the growing acceptance of cannabis for medical and recreational use.

Wichtige Kunden

  • Medical cannabis patients seeking treatment.
  • Recreational cannabis users.
  • Consumers of cannabis-based health and wellness products.
  • Individuals seeking cannabis education.
KI-Zuversicht: 79% Aktualisiert: 17. März 2026

Finanzdaten

Chart & Info

Aleafia Health Inc. (ALEAF) Aktienkurs: Price data unavailable

Aktuelle Nachrichten

Analystenkonsens

Konsens-Bewertung

Aggregierte Kauf-/Halten-/Verkauf-Empfehlungen von Benzinga, Yahoo Finance und Finnhub fuer ALEAF.

Kursziele

Wall-Street-Kurszielanalyse fuer ALEAF.

MoonshotScore

38/100

Was bedeutet diese Bewertung?

Der MoonshotScore bewertet das Wachstumspotenzial von ALEAF auf einer Skala von 0-100 ueber mehrere Faktoren wie Innovation, Marktdisruption, finanzielle Gesundheit und Momentum.

Wettbewerber & Vergleichsunternehmen

Fuehrung: Patricia Symmes

CEO

Patricia Symmes is the CEO of Aleafia Health Inc. Her background includes experience in managing teams and overseeing operations within the healthcare sector. She has demonstrated leadership in guiding the company through various stages of growth and development. Her expertise lies in strategic planning, operational efficiency, and market expansion. She is responsible for driving the company's vision and ensuring its long-term success in the competitive cannabis industry.

Erfolgsbilanz: Under Patricia Symmes' leadership, Aleafia Health has focused on expanding its product portfolio and strengthening its presence in the Canadian cannabis market. Key milestones include the launch of new product lines and the expansion of the company's virtual clinic network. She has also overseen efforts to improve operational efficiency and reduce costs. Her strategic decisions have aimed to position Aleafia Health for long-term growth and profitability.

ALEAF OTC-Marktinformationen

OTC Other, also known as the Pink Market, represents the lowest tier of the OTC market. Companies in this tier may not meet minimum financial standards and have limited reporting requirements. Unlike companies listed on major exchanges like NYSE or NASDAQ, OTC Other companies often have less stringent listing requirements, resulting in higher risk and volatility for investors. Information availability may be limited, and trading volumes can be thin, making it difficult to execute large trades without significantly impacting the price.

  • OTC-Stufe: OTC Other
  • Offenlegungsstatus: Unknown
Liquiditaet: Liquidity for Aleafia Health Inc. on the OTC market is likely limited due to its listing on the OTC Other tier. Trading volume may be low, and the bid-ask spread could be wide, making it challenging to buy or sell shares quickly and efficiently. Investors may experience difficulty in executing large trades without significantly affecting the stock price. This lack of liquidity increases the risk of price volatility and potential losses.
OTC-Risikofaktoren:
  • Limited financial disclosure requirements.
  • Potential for fraud or manipulation.
  • Thin trading volume and wide bid-ask spreads.
  • Higher price volatility compared to exchange-listed stocks.
  • Risk of delisting or suspension of trading.
Sorgfaltspruefung-Checkliste:
  • Verify the company's financial statements and SEC filings (if available).
  • Research the company's management team and their track record.
  • Assess the company's business model and competitive landscape.
  • Review the company's legal and regulatory compliance.
  • Evaluate the company's liquidity and trading volume.
  • Understand the risks associated with investing in OTC stocks.
  • Consult with a financial advisor before making any investment decisions.
Legitimitaetssignale:
  • Operation of a virtual network of medical cannabis clinics.
  • Established brands such as Divvy and Emblem.
  • International presence.
  • Presence of a CEO and management team.

Aleafia Health Inc. Aktie: Wichtige Fragen beantwortet

What are the key factors to evaluate for ALEAF?

Aleafia Health Inc. (ALEAF) currently holds an AI score of 38/100, indicating low score. Key strength: Diverse product portfolio including oils, edibles, and dried flower.. Primary risk to monitor: Ongoing: Increasing competition from other cannabis producers in a saturated market.. This is not financial advice.

How frequently does ALEAF data refresh on this page?

ALEAF prices update in real time during U.S. market hours (9:30 AM-4:00 PM ET, weekdays). Fundamentals refresh after quarterly or annual filings. Analyst ratings and AI insights update daily. News is aggregated continuously from financial sources.

What has driven ALEAF's recent stock price performance?

Recent price movement in Aleafia Health Inc. (ALEAF) can be influenced by earnings results, analyst revisions, sector rotation, and broader market sentiment. Notable catalyst: Diverse product portfolio including oils, edibles, and dried flower.. Check the News and Technical Analysis tabs for the latest drivers. Past performance does not predict future results.

Should investors consider ALEAF overvalued or undervalued right now?

Determining whether Aleafia Health Inc. (ALEAF) is overvalued or undervalued requires examining multiple metrics. Compare valuation ratios (P/E, P/S, EV/EBITDA) against sector peers for a comprehensive view.

What research should beginners do before buying ALEAF?

Before investing in Aleafia Health Inc. (ALEAF), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) what Wall Street analysts recommend and their price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).

Why might investors consider adding ALEAF to a portfolio?

Potential reasons to consider Aleafia Health Inc. (ALEAF) depend on individual investment goals and risk tolerance. A key strength identified by analysis: Diverse product portfolio including oils, edibles, and dried flower.. Additionally: Virtual network of medical cannabis clinics.. Always weigh potential rewards against risks and diversify across holdings. This is not financial advice.

Can I buy fractional shares of ALEAF?

Yes, most major brokerages offer fractional shares of Aleafia Health Inc. (ALEAF) with no minimum purchase requirement. This means you can invest any dollar amount regardless of the share price. Check your brokerage platform for specific terms, fees, and fractional share availability.

How can I track ALEAF's earnings and financial reports?

Aleafia Health Inc. (ALEAF) reports quarterly earnings approximately 4-6 weeks after each fiscal quarter ends. You can track earnings dates, revenue and EPS estimates, and actual results on this page's Financials tab. Earnings surprises (beats or misses) often cause significant short-term price moves. Setting up alerts through your brokerage for ALEAF earnings announcements is recommended.

Haftungsausschluss: Dieser Inhalt dient ausschliesslich zu Informationszwecken und stellt keine Anlageberatung dar. Fuehren Sie immer Ihre eigene Recherche durch und konsultieren Sie einen Finanzberater.

Offizielle Ressourcen

Analyse aktualisiert am KI-Bewertung taeglich aktualisiert
Datenquellen & Methodik
Marktdaten bereitgestellt von Financial Modeling Prep & Yahoo Finance. KI-Analyse durch proprietaere Algorithmen von Stock Expert AI. Technische Indikatoren nach branchenueblichen Berechnungsstandards. Zuletzt aktualisiert: .

Daten dienen ausschliesslich zu Informationszwecken.

Analysehinweise
  • Financial data may be limited due to the company's OTC listing.
  • AI analysis pending for ALEAF.
Datenquellen

Popular Stocks